Trial of Adherence App for Buprenorphine Treatment (TAAB) Study

NACompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

February 15, 2019

Primary Completion Date

May 15, 2020

Study Completion Date

July 29, 2020

Conditions
Opioid-Related Disorders
Interventions
BEHAVIORAL

Video-based DOT Application

Participants will be asked to record daily videos of themselves confirming daily ingestion of their buprenorphine. Clinical staff (i.e. physicians, nurses and medical assistants) of patients enrolled in the intervention group will be given training and the opportunity to review medication taking videos.

Trial Locations (2)

98104

University of Washington, Seattle

02118

Boston University, Boston

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

emocha Mobile Health, Inc.

OTHER

lead

University of Washington

OTHER

NCT03779997 - Trial of Adherence App for Buprenorphine Treatment (TAAB) Study | Biotech Hunter | Biotech Hunter